The Law Offices of Bailey & Burke

A Proven Full Service Law Firm Since 1971

The Law Offices of Bailey & Burke

A Proven Full Service Law Firm Since 1971

  1. Home
  2.  → 
  3. Personal Injury
  4.  → Understanding product liability claims against Zantac

Understanding product liability claims against Zantac

On Behalf of | Jun 2, 2023 | Personal Injury

A popular over-the-counter medication, Zantac has come under scrutiny due to its potential link to serious health concerns. Consumers have been raising concerns and initiating product liability claims against the manufacturers of this drug.

The heart of the issue lies in the potential risks and side effects linked to Zantac.

The dangers associated with Zantac

Zantac, also known as ranitidine, is a medication often used to treat heartburn and stomach ulcers. Recently, experts have linked Zantac to potential carcinogenic effects. This is due to the presence of N-nitrosodimethylamine (NDMA), a probable human carcinogen, in the medication. Long-term exposure to NDMA can increase the risk of developing certain types of cancers.

Side effects consumers are experiencing

Side effects reported by consumers include typical symptoms such as headaches, dizziness and stomach discomfort. However, more severe side effects linked to long-term use and exposure to NDMA can include jaundice, irregular heartbeat and in severe cases, the development of cancer. People who have been taking Zantac regularly and for an extended period are at a higher risk.

Ongoing litigation against Zantac

Consumers have filed numerous lawsuits against the manufacturers of Zantac, alleging that they knew about the potential risks associated with the drug but failed to warn consumers. These lawsuits seek compensation for medical expenses, pain and suffering and in some cases, punitive damages. However, it is essential to note that litigation is a lengthy process, and the outcome remains uncertain.

What consumers should know

Consumers should be aware that many stores have pulled Zantac, and the FDA has requested the removal of all prescription and over-the-counter ranitidine drugs from the market. Those who have been using Zantac regularly should consult their healthcare provider for alternative medications.

The situation with Zantac underscores the importance of transparency and safety in the pharmaceutical industry. Consumers trust that the medications they take are safe and that any potential risks are clearly communicated. When companies break this trust, consumers can hold them accountable.


FindLaw Network